Giannos P et al. concluded from the bioinformatic analysis that SPP1 may be a potential biomarker of genes and a predictor of IFX treatment resistance in the development of UC and CRC (Giannos et al., 2022). Here, SPP1 is linked to colorectal carcinoma.